Technical Analysis for TRVN - Trevena, Inc.

Grade Last Price % Change Price Change
grade F 1.22 4.27% 0.05
TRVN closed up 4.27 percent on Friday, May 24, 2019, on 62 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TRVN trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish 4.27%
Expansion Breakdown Bearish Swing Setup 4.27%
Reversal New Lows Setup Bearish Swing Setup 4.27%
Lower Bollinger Band Walk Weakness 4.27%
Below Lower BB Weakness 4.27%
Lower Bollinger Band Touch Weakness 4.27%

Older signals for TRVN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Trevena, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing therapeutics for G protein coupled receptors. Its products include TRV027 that has completed Phase 2a clinical trials for the treatment of acute heart failure; TRV130, a small molecule G protein biased ligand at the µ-opioid receptor has completed Phase 1b clinical trials to treat moderate to severe acute pain intravenously; TRV734 that is in preclinical studies as a orally administered treatment of moderate to severe acute and chronic pain; and d-opioid receptor G protein biased ligand therapeutics for the treatment of central nervous system disorders. The company was formerly known as Parallax Therapeutics, Inc. and changed its name to Trevena, Inc. in January 2008. Trevena, Inc. was founded in 2007 and is based in King of Prussia, Pennsylvania.
Pain Organic Compounds Central Nervous System Disorders Analgesics Cell Signaling Pyridines Signal Transduction Treatment Of Central Nervous System Disorders Opioid Acute Heart Failure Thiophenes Trevena Inc
Is TRVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.58
52 Week Low 0.38
Average Volume 1,386,724
200-Day Moving Average 1.2554
50-Day Moving Average 1.5074
20-Day Moving Average 1.405
10-Day Moving Average 1.31
Average True Range 0.0924
ADX 21.34
+DI 10.7118
-DI 29.7653
Chandelier Exit (Long, 3 ATRs ) 1.3728
Chandelier Exit (Short, 3 ATRs ) 1.4272
Upper Bollinger Band 1.6286
Lower Bollinger Band 1.1814
Percent B (%b) 0.09
BandWidth 31.829181
MACD Line -0.0718
MACD Signal Line -0.0475
MACD Histogram -0.0243
Fundamentals Value
Market Cap 72.83 Million
Num Shares 59.7 Million
EPS -1.94
Price-to-Earnings (P/E) Ratio -0.63
Price-to-Sales 0.00
Price-to-Book 1.66
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.34
Resistance 3 (R3) 1.33 1.28 1.32
Resistance 2 (R2) 1.28 1.25 1.29 1.31
Resistance 1 (R1) 1.25 1.23 1.27 1.26 1.31
Pivot Point 1.20 1.20 1.21 1.21 1.20
Support 1 (S1) 1.17 1.17 1.19 1.18 1.13
Support 2 (S2) 1.12 1.15 1.13 1.13
Support 3 (S3) 1.09 1.12 1.12
Support 4 (S4) 1.10